Biocon Limited · NSE:BIOCON
Biocon — Fact Sheet (June 2017)
4 slides from Biocon's fact sheet, June 2017
Slide 1: Biocon Group Fact Sheet June 2017
BIOCON GROUP FACT SHEET June ‐ 2017
Slide 2: Biocon Limited (Consolidated) Balance Sheet
BIOCON LIMITED (CONSOLIDATED) BALANCE SHEET (Rs Cr) June 30, 2017 March 31, 2017 ASSETS Non‐current assets (a) Property, plant and equipment 3,506 3,553 (b) Capital work‐in‐progress 613 533 (c) Investment property 1 1 (d) Goodwill 26 26 (e) Other intangible assets 43 46 (f) Intangible assets under d
Slide 3: Biocon Limited (Consolidated) Profit & Loss Statement
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Q1 Q1 Variance Particulars FY 18 FY 17 IndAS INCOME Small molecules 363 435 ‐17% Biologics 184 161 15% Branded formulations 130 158 ‐17% Research services 291 275 6% Inter‐segment (34) (37) ‐5% Revenue from operations # 934 992 ‐6% O
Slide 4: Biocon Limited (Consolidated) Profit & Loss Statement, Q1 FY18 vs Q4 FY17
BIOCON LIMITED (CONSOLIDATED) PROFIT & LOSS STATEMENT (Rs. Crores) Q1 Q4 Variance Particulars FY 18 FY 17 IndAS INCOME Small molecules 363 395 ‐8% Biologics 184 163 13% Branded formulations 130 131 0% Research services 291 283 3% Inter‐segment (34) (41) ‐15% Revenue from operations # 934 931 0% Othe